wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27670943-98066551-6E98-4431-B94F-CD0595DAA414
Q27670943-98066551-6E98-4431-B94F-CD0595DAA414
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27670943-98066551-6E98-4431-B94F-CD0595DAA414
CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells
P2860
Q27670943-98066551-6E98-4431-B94F-CD0595DAA414
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27670943-98066551-6E98-4431-B94F-CD0595DAA414
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ba8af4577be87655f9a41fce01303356a5f88f91
P2860
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days